These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31072339)

  • 1. Prognostic relevance of topoisomerase II α and minichromosome maintenance protein 6 expression in colorectal cancer.
    Hendricks A; Gieseler F; Nazzal S; Bräsen JH; Lucius R; Sipos B; Claasen JH; Becker T; Hinz S; Burmeister G; Schafmayer C; Schrader C
    BMC Cancer; 2019 May; 19(1):429. PubMed ID: 31072339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase IIα) in borderline ovarian tumors: Correlation with clinicopathological features.
    Ciepliński K; Jóźwik M; Semczuk-Sikora A; Gogacz M; Lewkowicz D; Ignatov A; Semczuk A
    Histol Histopathol; 2018 Feb; 33(2):171-179. PubMed ID: 28493257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
    Hotton J; Agopiantz M; Leroux A; Charra-Brunaud C; Marie B; Busby-Venner H; Morel O; Guéant JL; Vignaud JM; Battaglia-Hsu SF; Gauchotte G
    Virchows Arch; 2018 Apr; 472(4):623-633. PubMed ID: 29243125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.
    Xu J; Zhang S; You C; Huang S; Cai B; Wang X
    J Neurooncol; 2007 Jun; 83(2):183-9. PubMed ID: 17410335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.
    Vigouroux C; Casse JM; Battaglia-Hsu SF; Brochin L; Luc A; Paris C; Lacomme S; Gueant JL; Vignaud JM; Gauchotte G
    Lung Cancer; 2015 Aug; 89(2):189-96. PubMed ID: 26013954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.
    An X; Xu F; Luo R; Zheng Q; Lu J; Yang Y; Qin T; Yuan Z; Shi Y; Jiang W; Wang S
    BMC Cancer; 2018 Mar; 18(1):331. PubMed ID: 29587760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
    Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
    Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases.
    Rudolph P; MacGrogan G; Bonichon F; Frahm SO; de Mascarel I; Trojani M; Durand M; Avril A; Coindre JM; Parwaresch R
    Breast Cancer Res Treat; 1999 May; 55(1):61-71. PubMed ID: 10472780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
    Erber R; Gluz O; Brünner N; Kreipe HH; Pelz E; Kates R; Bartels A; Huober J; Mohrmann S; Moustafa Z; Liedtke C; Möbus V; Augustin D; Thomssen C; Jänicke F; Kiechle M; Kuhn W; Nitz U; Harbeck N; Hartmann A
    Breast Cancer Res Treat; 2015 Apr; 150(2):279-88. PubMed ID: 25721604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining topoisomerase isoforms in gastric cancer.
    Hou G; Deng J; You X; Chen J; Jiang Y; Qian T; Bi Y; Song B; Xu Y; Yang X
    Gene; 2020 Sep; 754():144859. PubMed ID: 32535049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome.
    Lodge AJ; Hall AG; Reid MM; McIntosh GG; Steward M; Anderson JJ; Horne CH; Angus B
    J Clin Pathol; 2001 Jan; 54(1):31-6. PubMed ID: 11271785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
    Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
    J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Minichromosome Maintenance Protein 6 Expression Rate and Clinical Outcome in Patients With Hodgkin's Lymphoma.
    Khodadad K; Karimi S; Esfahani-Monfared Z; Khosravi A; Bandarchi-Chamkhaleh B
    Acta Med Iran; 2017 Sep; 55(9):550-555. PubMed ID: 29202546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas.
    Shibao K; Takano H; Nakayama Y; Okazaki K; Nagata N; Izumi H; Uchiumi T; Kuwano M; Kohno K; Itoh H
    Int J Cancer; 1999 Dec; 83(6):732-7. PubMed ID: 10597187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
    Lynch BJ; Guinee DG; Holden JA
    Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 and TOP2A Gene Amplification and Protein Expression in Upper Tract Urothelial Carcinomas.
    Aumayr K; Klatte T; Neudert B; Birner P; Shariat S; Schmidinger M; Susani M; Haitel A
    Pathol Oncol Res; 2018 Jul; 24(3):575-581. PubMed ID: 28755093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.